Immunolocalization of inducible nitric oxide synthase in synovium and cartilage in rheumatoid arthritis and osteoarthritis

British Journal of Rheumatology

Volumn 36, Issue 6, 1997, Pages 651-655

  Grabowski, P S ^a,c   Wright, P K ^a   Van 'T Hof, R J ^a   Helfrich, M H ^a   Ohshima, H ^b   Ralston, S H ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Cartilage; Nitric oxide; Rheumatoid arthritis; Synovitis

Indexed keywords

CD68 ANTIGEN; NITRIC OXIDE SYNTHASE;

ARTICLE; CARTILAGE; CARTILAGE CELL; CLINICAL ARTICLE; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MACROPHAGE; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIUM; VASCULAR SMOOTH MUSCLE;

EID: 0030750273     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/36.6.651     Document Type: Article

References (33)

1. Moncada S, Higgs A. The L-arginine nitric oxide pathway. N Engl J Med 1993;329:2002-12.
2. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992;6:3051-64.
3. Ignarro LJ, Buga GM, Woods KS, Bryns RE, Chauduri G. Endothelium derived relaxating factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987;84:9265-8.
4. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6.
5. Bredt DS, Snyder SH. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 1989;86:9030-3.
6. Stuehr DJ, Nathan CF. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumour target cells. J Exp Med 1989;169:1543-55.
7. Wei X, Charles IG, Smith A, Ure J, Feng G, Huang F et al. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 1995;375:408-11.
8. Stefanovic-Racic M, Stadler J, Evans CH. Nitric oxide and arthritis. Arthritis Rheum 1993;36:1036-44.
9. Farrell AJ, Blake DR, Palmer RMJ, Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 1992;51:1219-22.
10. Grabowski PS, England A, Dijkhuisen R, Copeland M, Benjamin N, Reid D et al. Detection of increased nitric oxide production in rheumatoid arthritis using the urinary nitrate/creatinine ratio. Arthritis Rheum 1996;39:643-7.
11. Grabowski PS, MacPherson HM, Ralston SH. Nitric oxide production in cells derived from the human joint. Br J Rheumatol 1995;35:207-13.
12. Ralston SH, Todd D, Helfrich MH, Benjamin N, Grabowski P. Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase. Endocrinology 1994;135:330-6.
13. Palmer RMJ, Hickery MS, Charles IG, Moncada S, Bayliss MT. Induction of nitric oxide synthase in human chondrocytes. Biochem Biophys Res Commun 1993; 193:398-405.
14. Sakurai H, Koshaka H, Lui M, Higashiyama H, Hirata Y, Kanno K et al. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest 1995;96:2357-63.
15. Ohshima H, Brouet IM, Bandaletova T, Adachi H, Oguchi S, Iida S et al. Polyclonal antibody against an inducible form of nitric oxide synthase purified from the liver of rats treated with Propionibacterium acnes and lipopolysaccharide. Biochem Biophys Res Commun 1992;187:1291-7.
16. Bandaletova T, Brouet I, Bartsch H, Sugimura T, Esumi H, Ohshima H. Immunohistochemical localization of an inducible form of nitric oxide synthase in various organs of rats treated with Propionibacterium acnes and lipopolysaccharide. APMIS 1993;101:330-6.
17. Cutolo M, Sulli A, Barone A, Seriolo B, Accardo S. Macrophages, synovial tissue and rheumatoid arthritis. Clin Exp Rheumatol 1993;11:331-9.
18. Gordon GV, Villaneuva T, Schuhmacher HR, Gohel V. Autopsy study correlating degree of osteoarthritis, synovitis and evidence of articular calcification. J Rheumatol 1984;11:681-6.
19. Kirkham B. Interleukin-1, immune activation pathways, and different mechanisms in osteoarthritis and rheumatoid arthritis. [Review] Ann Rheum Dis 1991;50:395-400.
20. Schneemann M, Schoeden G, Hofer S, Blau N, Guerrero L, Schaffner, A. Nitric oxide is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J Infect Dis 1993;167:1358-63.
21. Weinberg JB, Misukonis MA, Shami PJ, Mason SN, Sauls DL, Dittman WA et al. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood 1995;86:1184-95.
22. Stefanovic-Racic M, Morales TI, Taskiran D, McIntyre LA, Evans CH. The role of nitric oxide in proteoglycan turnover by bovine articular cartilage organ cultures. J Immunol 1996;156:1213-20.
23. Taskiran D, Stefanovic-Racic M, Georgescu H, Evans C. Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1. Biochem Biophys Res Commun 1994;200:142-8.
24. Murrell GA, Jang D, Williams RJ. Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem Biophys Res Commun 1995;206:15-21.
25. Ralston SH, Ho LP, Helfrich M, Grabowski PS, Johnston PW, Benjamin N. Nitric oxide: a cytokine induced regulator of bone resorption. J Bone Miner Res 1995;10:1040-9.
26. Sambrook PN, Reeve J. Bone disease in rheumatoid arthritis. Clin Sci 1988;74:225-30.
27. Gough AK, Lilley J, Eyre S, Holder RL, Emery P. Generalised bone loss in patients with early rheumatoid arthritis. Lancet 1994;344:23-7.
28. Mayhan WG. Role of nitric oxide in leukotriene C4-induced increases in micro vascular transport. Am J Physiol 1993;265:H409-14.
29. Mayhan WG. Role of nitric oxide in modulating permeability of hamster cheek pouch in response to adenosine 5′-diphosphate and bradykinin. Inflammation 1992;16:295-305.
30. Lander HM, Sehajpal P, Levine DM, Novogrodsky A. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J Immunol 1993;150:1509-16.
31. Leibovich SJ, Polverini PJ, Fong TW, Harlow LA, Koch AE. Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. Proc Natl Acad Sci USA 1994;91:4190-4.
32. Ialenti A, Moncada S, Di Rosa M. Modulation of adjuvant arthritis by endogenous nitric oxide. Br J Pharmacol 1993;110:701-6.
33. McCartney-Francis N, Allen JB, Mizel DE, Albina JE, Xie Q, Nathan CF et al. Supression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 1993;178:749-54.